US$ 22.82
glp 1 news today Eli Lilly to seek approval of new GLP-1 weight-loss drug this year Lilly is now pharma's top
Description
6 Application of GLP-1RA in tumors As a hypoglycemic agent, GLP-1RA has not been applied to the treatment of oncologic diseases alone, but studies on the correlation between GLP-1RA and tumors can also guide the use of drugs in patients with related tumor diseases

Subscribe to Scientific American for more up-to-date and in-depth science news

Wegovy has been clinically studied for weight management

Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells
